Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Sionna adds $182M to extend pipeline, cash runway through 2026
Sionna CEO Mike Cloonan said the company's series C will be its last private financing.
Max Bayer
Mar 6, 2024 8:00am
Latigo raises $135M to catch up to Vertex in chronic pain
Feb 14, 2024 5:00am
Vertex meets own cystic fibrosis record with next-gen treatment
Feb 5, 2024 7:50pm
Vertex's phase 3 pain trials hit goals but fail to beat Vicodin
Jan 30, 2024 8:00am
Vertex cuts ties to CRISPR’s type 1 diabetes stem cell therapy
Jan 8, 2024 9:16am
Vertex pauses diabetes cell therapy trial after 2 deaths
Jan 7, 2024 5:00pm